EUVIMEDEUVIMED entdecken
Crossref

Synergistic Genetic and Chemical Engineering of Probiotics for Enhanced Intestinal Microbiota Regulation and Ulcerative Colitis Treatment

Jiani Jiang, Yi Ma, Liang Zhou, Wenfang Han, Ying Liang, Jiangyan Dong, Yuqin Ding, Wen Li, Qi Lei, Jiangtao Li, Wei Zhu iD, Qinlu Lin

Advanced Materials · 2025-07 · 37 (30)

DOI: 10.1002/adma.202417050 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, 2025-06. Verfasst von Jiani Jiang und 11 weiteren Autor:innen. Beteiligte Einrichtung: National Engineering Research Center of Rice and Byproduct Deep Processing, College of Food Science and Engineering, Central South University of Fore…. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Probiotics, Gastrointestinal Microbiome, Chemical Engineering. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Science and Technology Innovation Program of Hunan Province, Guangzhou Science and Technology Plan Project, Program for Guangdong Introducing Innovative and Entrepreneurial Teams.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Live bacterial therapeutics (LBT) hold significant promise for treating ulcerative colitis (UC) by utilizing engineered microorganisms to restore mucosal barrier function, modulate microbiota imbalances, and enhance immunity. However, challenges such as low bacterial survival under harsh gastrointestinal conditions, difficulties in achieving long‐term colonization, and unclear therapeutic targets limit their effectiveness. To address these issues, a novel approach is proposed that integrates genetic and chemical engineering for intestinal flora regulation in UC treatment. This strategy employs bacterial programmability and gene editing to produce bactericidal agents that dynamically modulate the intestinal microecology and utilize controlled chemical modifications to enhance bacterial resistance. Using Escherichia coli Nissle 1917 (EcN) as a model, a polyelectrolyte composite coating is developed that significantly increased bacterial survival in the gastrointestinal tract—40‐fold in the stomach and 74‐fold in the small intestine. Additionally, EcN::mcmA is engineered to overproduce iron‐carrier microcins (MccM) with a “Trojan horse” mechanism to target and disrupt pathogenic bacteria. In a dextran sulfate sodium (DSS)‐induced mouse UC model, EcN::mcmA@P/O treatment effectively reduced inflammation and improved intestinal flora regulation, presenting a promising and potentially safer long‐term solution for UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeProbioticsGastrointestinal MicrobiomeChemical EngineeringGenetic EngineeringAnimalsMiceEscherichia coliDextran SulfateMice, Inbred C57BLDisease Models, Animal

Stichwörter der Autor:innen

chemical modificationengineered probioticsintestinal floralive bacterial therapeuticsulcerative colitis

Substanzen

Dextran Sulfate

Autor:innen und Institutionen

  • National Engineering Research Center of Rice and Byproduct Deep Processing, College of Food Science and Engineering, Central South University of Forestry and Technology, Changsha, 410004, P. R. China.
  • MOE International Joint Research Laboratory on Synthetic Biology and Medicines, School of Biology and Biological Engineering, South China University of Technology, Guangzhou, 510006, P. R. China.
  • The Second Affiliated Hospital, Provincial Key Laboratory of Allergy & Clinical Immunology, Guangzhou Medical University, Guangzhou, 510260, P. R. China.

ORCID-Profile: Wei Zhu

Förderung

  • Science and Technology Innovation Program of Hunan Province
  • Guangzhou Science and Technology Plan Project
  • Program for Guangdong Introducing Innovative and Entrepreneurial Teams
  • Natural Science Foundation of Guangdong Province
  • Guangdong Key Areas R&D Program
  • Science and Technology Project of Guangzhou
  • Guangdong Provincial Pearl River Talents Program
  • National Natural Science Foundation of China

Zitieren

APA

Jiang, J., Ma, Y., Zhou, L., Han, W., Liang, Y., Dong, J., Ding, Y., Li, W., Lei, Q., Li, J., Zhu, W., & Lin, Q. (2025). Synergistic Genetic and Chemical Engineering of Probiotics for Enhanced Intestinal Microbiota Regulation and Ulcerative Colitis Treatment. Advanced Materials, 37(30). https://doi.org/10.1002/adma.202417050

Vancouver

Jiang J, Ma Y, Zhou L, Han W, Liang Y, Dong J, et al. Synergistic Genetic and Chemical Engineering of Probiotics for Enhanced Intestinal Microbiota Regulation and Ulcerative Colitis Treatment. Advanced Materials. 2025;37(30). doi:10.1002/adma.202417050

BibTeX
@article{Jiang2025,
  author = {Jiang, Jiani and Ma, Yi and Zhou, Liang and Han, Wenfang and Liang, Ying and Dong, Jiangyan and Ding, Yuqin and Li, Wen and Lei, Qi and Li, Jiangtao and Zhu, Wei and Lin, Qinlu},
  title = {Synergistic Genetic and Chemical Engineering of Probiotics for Enhanced Intestinal Microbiota Regulation and Ulcerative Colitis Treatment},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {30},
  doi = {10.1002/adma.202417050}
}
Kostenlos starten →